AAP
APTO

Arax Advisory Partners’s Aptose Biosciences, Inc. APTO Stock Holding History

Arax Advisory Partners’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1
Closed -$3K – 720
2020
Q2 		$3K Hold
1
– – ﹤0.01% 624
2020
Q1 		$3K Buy
+1
New +$2.98K ﹤0.01% 616

Other funds holding APTO

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Arax Advisory Partners's APTO Position: Q3 2020 in Review

Arax Advisory Partners sold out of Aptose Biosciences, Inc. (APTO) in Q3 2020, closing a stake of 1 share — an estimated $3K sold.

Arax Advisory Partners first reported a position in APTO in Q1 2020 and held it in 2 quarters. The position peaked at $3K in Q2 2020. 64 funds tracked by Wall St. Rank hold APTO as of Q3 2020.

  • Arax Advisory Partners reported no remaining Aptose Biosciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • Arax Advisory Partners sold 1 Aptose Biosciences, Inc. share in Q3 2020, an estimated $3K.
  • Arax Advisory Partners first reported a position in Aptose Biosciences, Inc. in Q1 2020 and held it in 2 quarters.
  • Arax Advisory Partners's Aptose Biosciences, Inc. position peaked at $3K in Q2 2020.
  • 64 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2020.

Based on Arax Advisory Partners's 13F filing for Q3 2020, filed 12 Nov 2020.